Here are 1-3 brief analogies for TechPrecision (TPCS):

• TechPrecision is like a smaller, highly specialized version of Precision Castparts Corp. (PCC), manufacturing critical metal components for demanding industries like defense, aerospace, and medical.
• TechPrecision is like a high-precision contract manufacturer, similar to Jabil, but specialized in complex, custom metal components for critical industries like defense, aerospace, and medical.
• TechPrecision is like the 'foundry' for high-precision metal components, similar to how TSMC manufactures critical semiconductors for tech giants, but TechPrecision specializes in structural metal parts for industries like defense, aerospace, and medical.

• Custom Defense & Aerospace Components: Precision-machined and fabricated metal structural components for ships, submarines, helicopters, and general aerospace equipment.
• Nuclear Power Plant Components: Specialized metal components designed for use in nuclear power generation facilities.
• Medical System Components: Custom-manufactured metal parts and systems for various medical devices and equipment.

Based on its public filings, TechPrecision Corporation (TPCS) does not disclose any single customer accounting for 10% or more of its net sales in recent fiscal years. Therefore, no individual "major customers" by name, along with their symbols, can be identified as per typical SEC disclosure requirements.

However, TechPrecision primarily sells its precision-fabricated and machined metal structural components and systems to other companies within specific high-precision industries. The company's finished products are used by customers in the following key markets/categories:

• Companies in the Defense Sector (e.g., contractors for ships, submarines, and helicopters).
• Companies in the Aerospace Sector (e.g., manufacturers of aerospace equipment).
• Companies in the Nuclear Sector (e.g., manufacturers of components for nuclear power plants).
• Companies in the Medical Sector (e.g., manufacturers of components for medical systems).
• Companies in the Precision Industrial Sector.

Alexander Shen, Chief Executive Officer

Alexander Shen was appointed Chief Executive Officer of TechPrecision in November 2014, bringing over a decade of leadership to the company. He also served as interim principal financial officer and principal accounting officer from February 2025, after the resignation of the former CFO, until Phillip E. Podgorski officially took over the CFO role.

Phillip E. Podgorski, Chief Financial Officer

Phillip E. Podgorski was appointed Chief Financial Officer of TechPrecision Corporation, effective March 31, 2025. He assumed the responsibilities of principal financial officer and principal accounting officer after the filing of the company's quarterly report for the period ending December 31, 2024. Prior to joining TechPrecision, Mr. Podgorski served as the Chief Financial Officer for the RTX Technology Research Center (RTRC), a division of RTX Corporation, a public aerospace and defense company, since 2013. In this role, he was responsible for all GAAP, SEC, and government accounting and reporting aspects for RTRC, and was also involved in strategic and scenario planning. He holds an MBA and a Bachelor of Science degree in Accounting from Western New England University.

Barbara M. Lilley, Controller (of a subsidiary)

Barbara M. Lilley served as TechPrecision's Interim Chief Financial Officer and stepped down from that role upon Phillip E. Podgorski's appointment. She retains her position as Controller of Ranor, Inc., a wholly-owned subsidiary of TechPrecision Corporation.

The key risks to TechPrecision's business include ongoing financial reporting challenges leading to Nasdaq non-compliance, persistent operating losses and performance issues at its STADCO subsidiary, and significant working capital and liquidity concerns.

1. Financial Reporting Challenges and Nasdaq Non-Compliance: TechPrecision has repeatedly failed to timely file its quarterly and annual reports (Forms 10-Q and 10-K) with the SEC. These delays have resulted in multiple notifications of non-compliance from Nasdaq, raising the risk of the company's common stock being delisted. The company has attributed these delays to difficulties integrating STADCO's financial reporting system and ongoing staffing issues within its financial departments.
2. Operating Losses and Performance Issues at STADCO Subsidiary: The company's STADCO subsidiary has consistently experienced declining revenue and operating losses. Factors contributing to these issues include an unfavorable project mix, higher provisions for projected contract losses, and the impact of legacy and underpriced contracts. This segment's underperformance significantly impacts TechPrecision's overall consolidated financial results and profitability.
3. Working Capital Challenges and Debt/Liquidity Concerns: TechPrecision has faced a negative working capital position and has reported total debt, which has raised concerns about its liquidity. In some instances, all long-term debt has been classified as current due to certain debt covenant violations. The company has also indicated that it does not anticipate paying cash dividends in the foreseeable future, partly due to restrictions under its credit facility, further highlighting its financial constraints.

TechPrecision Corporation (NASDAQ: TPCS) operates in several addressable markets within the United States, providing precision, fabricated, and machined metal structural components and systems. The company's main products and services cater to the defense, aerospace, nuclear, medical, and precision industrial sectors.

Addressable Markets for TechPrecision's Products and Services:

• Defense: The U.S. defense market size reached approximately $654.98 billion in 2025. This market is forecast to increase by $188 billion with a compound annual growth rate (CAGR) of 4.6% between 2024 and 2029. TechPrecision supplies custom components for U.S. Navy submarine programs, as well as for ships, submarines, and helicopters.
• Aerospace: The U.S. aerospace parts manufacturing market was valued at an estimated $424.3 billion in 2023 and is projected to grow to $476.00 billion by 2030, with a CAGR of 1.7% from 2024 to 2030. TechPrecision manufactures components for aerospace equipment.
• Nuclear: The U.S. nuclear power market was valued at $13.3 billion in 2024 and is expected to reach $19.6 billion by 2032, growing at a CAGR of 5.1% from 2025 to 2032. TechPrecision provides components for nuclear power plants.
• Medical Systems: The U.S. medical device manufacturers market was estimated at $256.2 billion in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2030, reaching $360.1 billion by 2030. TechPrecision supplies components for medical systems.
• Precision Industrial: The North American precision parts market, which includes precision industrial components, was valued at approximately $72.81 billion in 2024. The U.S. precision parts market was valued at $36 billion in 2020 and is estimated to reach $71 billion by 2026, with a CAGR of 12% during that period. TechPrecision manufactures precision industrial components.

TechPrecision Corporation (TPCS) is expected to experience future revenue growth over the next 2-3 years, driven by several key factors:

1. Strong and Growing Backlog: The company consistently reports a significant funded backlog that provides clear revenue visibility for the coming years. As of December 31, 2024, the backlog stood at $45.5 million, anticipated to be delivered over the next one to three fiscal years with expected gross margin expansion. More recently, as of December 31, 2025, the backlog was $46.0 million, and earlier in fiscal year 2026, it reached $50.1 million, further demonstrating strong customer confidence and future revenue streams.

2. Continued Focus on the Defense Sector and Navy Grants: TechPrecision's strategic emphasis on the defense sector, particularly naval submarine programs like the Virginia class and Columbia class, remains a primary growth driver. The Ranor segment has secured over $24 million in fully funded grant money from U.S. Navy submarine program customers, including a new grant of over $3.2 million. This ongoing support highlights robust demand within the defense industry and sustained investment in these critical programs.

3. Improved Project Mix and Enhanced Pricing Strategies: Management is actively working to enhance profitability, especially within the Stadco subsidiary, which has historically faced challenges with legacy pricing and unfavorable project mixes. The company is strategically pursuing new business opportunities with improved pricing. The Ranor segment has already demonstrated success with a favorable project mix, leading to improved gross margin and gross profit.

4. Strategic Capital Expenditures and Capacity Expansion: TechPrecision is investing in its capabilities and capacity to support future growth. The Ranor segment is undergoing a significant expansion with $10 million in Navy CAPEX funding designated to boost its capabilities and capacity over the next 24 months, aiming for increased revenue and EBITDA performance. Overall, the company has invested nearly $12 million in capital expenditures across both Ranor and STADCO, with an additional $10 million+ planned for the next 24 months to materially enhance machining and tooling capabilities.

5. New Business Awards and Sustained Customer Confidence: The company's CEO, Alexander Shen, has expressed confidence in future revenue growth stemming from new business awards and more favorable customer terms. The consistently strong backlog and ongoing efforts to secure new contracts, particularly in air defense and submarine defense, underscore continued customer confidence and provide avenues for further expansion.

Capital Allocation Decisions (Last 3-5 Years)

Share Repurchases

There is no information available in the provided search results regarding share repurchases made or authorized by TechPrecision Corporation over the last 3-5 years.

Share Issuance

• TechPrecision Corporation implemented a 1-for-4 reverse stock split, which became effective for trading on February 24, 2023.
• On April 29, 2024, the company issued 320,000 shares of common stock as a Stock Termination Fee related to the termination of a planned acquisition.
• As of March 31, 2025, the company had approximately 9.76 million shares issued and outstanding.

Inbound Investments

There is no information available in the provided search results regarding large inbound investments made in TechPrecision Corporation by third-parties over the last 3-5 years.

Outbound Investments

• TechPrecision entered into a Stock Purchase Agreement on November 22, 2023, to acquire Votaw Precision Technologies, Inc., but the acquisition ultimately failed due to a change in certain conditions and events by March 31, 2024.
• The company incurred approximately $1 million in one-time cash expenses for the fiscal year ended March 31, 2024, associated with the failed acquisition of Votaw Precision Technologies, Inc.
• During the third quarter of fiscal year 2024 (ended December 31, 2023), TechPrecision spent approximately $1.0 million on due diligence costs related to a potential acquisition.

Capital Expenditures

• TechPrecision Corporation reported -$4.74 million in capital expenditures over the past twelve months as of March 3, 2026.
• The company has purchase obligations for machinery and equipment reimbursable by a customer totaling approximately $7,483 as of August 21, 2025.